Table 1.
Enrolment characteristics | Treatment | Placebo | p Value | ||
---|---|---|---|---|---|
|
|||||
N | Per cent | N | Per cent | ||
Total | 148 | 100.0 | 153 | 100.0 | |
| |||||
Age (years) | 0.980 | ||||
20–29 | 37 | 25 | 36 | 24 | |
30–39 | 65 | 44 | 66 | 43 | |
40–49 | 31 | 21 | 35 | 23 | |
50+ | 15 | 10 | 16 | 10 | |
CD4+ T cell count | 0.564 | ||||
300–349 | 69 | 47 | 66 | 43 | |
350–399 | 79 | 53 | 87 | 57 | |
HIV Viral load categories | 0.973 | ||||
<10000 | 53 | 36 | 54 | 35 | |
10000–49999 | 43 | 29 | 43 | 28 | |
50000–99999 | 13 | 9 | 16 | 10 | |
100000+ | 39 | 26 | 40 | 26 | |
Log10 HIV viral load | |||||
Median (IQR) | 4.33 | (3.77–5.03) | 4.39 | (3.66–5.04) | 0.880 |
sCD14 | 0.300 | ||||
<Median | 79 | 53 | 72 | 47 | |
Median+ | 69 | 47 | 81 | 53 | |
Log10 sCD14 | |||||
Median (IQR) | 3.31 | (3.20–3.45) | 3.34 | (3.20–3.43) | 0.816 |
CRP | 0.084 | ||||
<Median | 82 | 55 | 69 | 45 | |
Median+ | 66 | 45 | 84 | 55 | |
Log10 CRP | |||||
Median (IQR) | 0.99 | (0.40–3.30) | 1.32 | (0.46–3.86) | 0.329 |
CRP, C-reactive protein.